COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 2179: Articles 21781-21790  | Next

School closures and SARS-CoV-2. Evidence from Sweden's partial school closure
Vlachos, J., Hertegard, E., Svaleryd, H. B.
10.1101/2020.10.13.20211359 — Posted: 2020-10-14
A comparative study of infection and mortality in COVID-19 across countries: A scaling analysis
Das, R., Hossain, A., Mandal, S., Pariari, D., Rohj, R. K., Shukla, S., Varma, R. M., Das Sarma, D.
10.1101/2020.10.13.20212175 — Posted: 2020-10-14
Mathematical Perspective of Covid-19 Pandemic: Disease Extinction Criteria in Deterministic and Stochastic Models
Adak, D., Majumder, A., Bairagi, N.
10.1101/2020.10.12.20211201 — Posted: 2020-10-14
Epidemiologial Analysis of Patients Presenting to a West London District General Hospital Requiring Admission with Covid-19
Heald, E., Ring, N., Vatvani, D., Shackleton, D.
10.1101/2020.10.13.20212126 — Posted: 2020-10-14
Healthcare workers with mild / asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave
Reynolds, C. J., Swadling, L., Gibbons, J. M., Pade, C., Jensen, M., Diniz, M. O., Schmidt, N. M., Butler, D. K., Amin, O. E., Bailey, S. N. L., Talyor, S., Jones, J., Jones, M., Lee, W. Y. J., Rosenheim, J., Chandran, A., Joy, G., Di Genova, C., Temperton, N. J., Lambourne, J., Cutino-Moguel, T., Andiapen, M., Fontana, M., Smit, A., Semper, A., O'Brien, B., Chain, B., Brooks, T., Manisty, C., Treibel, T., Moon, J., COVIDsortium Investigators, , Noursadeghi, M. C., COVIDsortium Immune correlates network, , Altmann, D. M., Mani, M. K., McKnight, A., Boyton, R. J.
10.1101/2020.10.13.20211763 — Posted: 2020-10-14
Prone positioning of non-intubated patients with COVID-19 - A Systematic Review and Meta-analysis
PONNAPA REDDY, M., SUBRAMANIAM, A., LIM, Z. J., ZUBAREV, A., AFROZ, A., BILLAH, B., TIRUVOIPATI, R., RAMANATHAN, K., WONG, S. N., BRODIE, D., FAN, E., SHEKAR, K.
10.1101/2020.10.12.20211748 — Posted: 2020-10-14
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
Dugas, M., Grote-Westrick, T., Vollenberg, R., Lorentzen, E., Brix, T., Schmidt, H., Tepasse, P.-R., Kuehn, J.
10.1101/2020.10.12.20211599 — Posted: 2020-10-14 Discussion: Onsite
Systematic analysis of electronic health records identifies drugs reducing risk of COVID-19 hospitalization and severity
Israel, A., Schaffer, A., Cicurel, A., Feldhamer, I., Tal, A., Cheng, K., Sinha, S., Schiff, E., Lavie, G., Ruppin, E.
10.1101/2020.10.13.20211953 — Posted: 2020-10-14
Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality criteria for services
Ladds, E., Rushforth, A., Wieringa, S., Taylor, S., Rayner, C., Husain, L., Greenhalgh, T.
10.1101/2020.10.13.20211854 — Posted: 2020-10-14 Discussion: Onsite
Clinical characteristics, symptoms, management and health outcomes in 8,598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal influenza in France, Spain and the US: a network cohort analysis
Lai, L. Y. H., Golozar, A., Sena, A. G., Margulis, A. V., Haro, N., Casajust, P., Valveny, N., Prats-Uribe, A., Minty, E. P., Ahmed, W. -U.-R., Alshammari, T. M., Morales, D. R., Alghoul, H., Alser, O., Dawoud, D., Zhang, L., Posada, J. D., Shah, N., Blacketer, C., Areia, C., Subbian, V., Nyberg, F., Lane, J. C. E., Suchard, M. A., Gong, M., Recalde, M., Jonnagaddala, J., Shah, K., Roel, E., Vizcaya, D., Fortin, S., Cheng, R.-f. J., Reich, C., Hripcsak, G., Rijnbeek, P., Ryan, P. B., Kostka, K., Duarte-Salles, T., PRIETO-ALHAMBRA, D.
10.1101/2020.10.13.20211821 — Posted: 2020-10-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).